Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001136472.2(LITAF):c.241G>A(p.Val81Met) variant causes a missense change. The variant allele was found at a frequency of 0.000157 in 1,613,950 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. V81L) has been classified as Uncertain significance.
LITAF (HGNC:16841): (lipopolysaccharide induced TNF factor) Lipopolysaccharide is a potent stimulator of monocytes and macrophages, causing secretion of tumor necrosis factor-alpha (TNF-alpha) and other inflammatory mediators. This gene encodes lipopolysaccharide-induced TNF-alpha factor, which is a DNA-binding protein and can mediate the TNF-alpha expression by direct binding to the promoter region of the TNF-alpha gene. The transcription of this gene is induced by tumor suppressor p53 and has been implicated in the p53-induced apoptotic pathway. Mutations in this gene cause Charcot-Marie-Tooth disease type 1C (CMT1C) and may be involved in the carcinogenesis of extramammary Paget's disease (EMPD). Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Dec 2014]
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.05255291).
BP6
Variant 16-11553669-C-T is Benign according to our data. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-11553669-C-T is described in CliVar as Likely_benign. Clinvar id is 317783.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000171 (26/152126) while in subpopulation AMR AF = 0.000131 (2/15264). AF 95% confidence interval is 0.0000226. There are 0 homozygotes in GnomAd4. There are 16 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Oct 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jan 09, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Inborn genetic diseasesBenign:1
Nov 05, 2021
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -